课题基金 / 基金详情

Studies of the t(2;13) of alveolar rhabdomyosarcoma

Studies of the t(2;13) of alveolar rhabdomyosarcoma
腺泡状横纹肌肉瘤t(2;13)的研究
批准号:
7257048
负责人:
FREDERIC G BARR
金额:
$33.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-30 至 2009-06-30

项目摘要

项目成果

FREDERIC G BARR的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肺泡横纹肌肉瘤(ARMS)是一种横纹肌谱系的侵袭性儿童癌症,其特征为2;13或1;13个染色体易位。这些事件将PAX3或PAX7与FKHR并置,产生编码PAX3-FKHR或PAX7-FKHR融合产物的融合基因。野生型基因编码转录因子,融合产物结合PAX3或PAX7 DNA结合域和FKHR激活域,产生有效的转录激活因子。虽然一些初步研究表明这些融合蛋白诱导致癌作用,但最近的研究揭示了遗传和表型的复杂性,需要改进这些融合产物在ARMS肿瘤发生中的作用模型。这些融合基因的基因转移研究证明了这些复杂性,这些融合基因在某些条件下显示出致癌行为,在其他条件下显示出生长抑制行为。此外,PAX3/PAX7-FKHR DNA结合域中存在频繁的选择性剪接事件,从而产生功能不同的异构体混合物。最后,ARMS细胞中存在继发性遗传变化,包括基因扩增和小突变,这些变化可能与易位事件相互作用。为了解释这些发现,我们提出了这样的假设:这些融合蛋白的生长效应最初取决于转录活性水平,在低活性时主要是致癌作用,在高活性时主要是生长抑制作用。这些生长效应之间的最终平衡以及额外的表型活动被认为是由其他因素调节的,包括功能不同的同种异构体和继发遗传变化的混合。目前的建议将重点放在PAX3-FKHR融合蛋白上,并将通过使用显示这一系列生长效应的诱导细胞培养系统来探索这些假设,以分析与致癌效应和生长抑制相关的功能需求和基因表达事件。细胞培养和体外系统将用于评估两种PAX3-FKHR亚型之间DNA结合活性、表型效应和下游表达事件的差异。最后,这些研究将探讨扩增的癌基因和其他遗传事件在改变融合蛋白的功能和下游效应中的作用。这些联合研究将能够全面评估PAX3-FKHR转录功能、靶基因表达、表型效应和协同事件之间的关系,从而更好地定义这些融合基因在ARMS肿瘤发生中的作用。
英文摘要
DESCRIPTION (provided by applicant): Alveolar rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer of the striated muscle lineage that is characterized by 2;13 or 1;13 chromosomal translocations. These events juxtapose PAX3 or PAX7 with FKHR to create fusion genes encoding PAX3-FKHR or PAX7-FKHR fusion products. The wild-type genes encode transcription factors, and the fusion products combine the PAX3 or PAX7 DNA binding domain and FKHR activation domain to create potent transcriptional activators. Though some initial studies indicated that these fusion proteins induce oncogenic effects, more recent studies have revealed genetic and phenotypic complexities that require refinement of the model for the role of these fusion products in ARMS tumorigenesis. These complexities are evidenced by gene transfer studies of these fusion genes that show oncogenic behavior in some conditions and growth suppressive behavior in other conditions. In addition, there are frequent alternative splicing events in the PAX3/PAX7-FKHR DNA binding domain that generate a mixture of functionally distinct isoforms. Finally, there are secondary genetic changes in ARMS cells, including gene amplification and small mutations, which may interact with the translocation events. To explain these findings, the hypothesis is proposed that the growth effects of these fusion proteins are initially dependent on the level of transcriptional activity, with oncogenic effects predominating at lower activity and growth suppression predominating at higher activity. The final balance between these growth effects as well as additional phenotypic activities is postulated to be modulated by other factors, including the mixture of functionally distinct isoforms and secondary genetic changes. The current proposal will focus on the PAX3-FKHR fusion protein and will explore these hypotheses by using inducible cell culture systems that display this range of growth effects to analyze the functional requirements and gene expression events associated with oncogenic effects and growth suppression. Cell culture and in vitro systems will be used to assess differences in DNA binding activity, phenotypic effects, and downstream expression events between the two PAX3-FKHR isoforms. Finally, these studies will investigate the role of amplified oncogenes and other genetic events in modifying the function and downstream effects of the fusion protein. These combined studies will permit a comprehensive evaluation of the relationship between PAX3-FKHR transcriptional function, target gene expression, phenotypic effects, and collaborating events, and will thereby better define the role of these fusion genes in ARMS tumorigenesis.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1541-7786.mcr-09-0259
发表时间: 2010-01
期刊: Molecular cancer research : MCR
影响因子: --
作者: [Tarnowski M, Grymula K, Reca R, Jankowski K, Maksym R, Tarnowska J, Przybylski G, Barr FG, Kucia M, Ratajczak MZ]
通讯作者: Ratajczak MZ
Molecular diagnosis of ewing family tumors: too many fusions... ?
尤文家族肿瘤的分子诊断:融合过多......?
DOI: 10.2353/jmoldx.2007.070080
发表时间: 2007
期刊: The Journal of molecular diagnostics : JMD
影响因子: --
作者: [Barr,FredericG, Womer,RichardB]
通讯作者: Womer,RichardB
DOI: 10.1002/ijc.25245
发表时间: 2010-12-01
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Grymula, Katarzyna, Tarnowski, Maciej, Wysoczynski, Marcin, Drukala, Justyna, Barr, Frederic G., Ratajczak, Janina, Kucia, Magdalena, Ratajczak, Mariusz Z.]
通讯作者: Ratajczak, Mariusz Z.
Genetics and the biologic basis of sarcomas.
肉瘤的遗传学和生物学基础。
DOI: 10.1097/00001622-199907000-00006
发表时间: 1999
期刊: Current opinion in oncology
影响因子: 3.4
作者: [Bennicelli,JL, Barr,FG]
通讯作者: Barr,FG
共 14 条
    DNA methylation-based assays for detecting disease spread in rhabdomyosarcoma
    • 批准号:
      7875543
    • 项目类别:
    • 资助金额:
      $17.4万
    • 财政年份:
      2010
    • 负责人:
      FREDERIC G BARR
    • 依托单位:
    COG studies of gene amplification in rhabdomyosarcoma
    • 批准号:
      7910236
    • 项目类别:
    • 资助金额:
      $13.0万
    • 财政年份:
      2009
    • 负责人:
      FREDERIC G BARR
    • 依托单位:
    COG studies of gene amplification in rhabdomyosarcoma
    • 批准号:
      7233681
    • 项目类别:
    • 资助金额:
      $41.37万
    • 财政年份:
      2005
    • 负责人:
      FREDERIC G BARR
    • 依托单位:
    COG studies of gene amplification in rhabdomyosarcoma
    • 批准号:
      7431756
    • 项目类别:
    • 资助金额:
      $41.71万
    • 财政年份:
      2005
    • 负责人:
      FREDERIC G BARR
    • 依托单位:
    国内基金
    海外基金
    毕节假单胞菌2P24中转录调控因子GacA影响高温适应性及生防性状的机制研究
    • 批准号:
      32460701
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2024
    • 负责人:
      吴小刚
    • 依托单位:
    荧光假单胞菌2P24中基因gcd对2,4-二乙酰基间苯三酚合成的调控机制研究
    荧光假单胞菌2P24中基因pqqF和gcd对抑菌物质DAPG合成的调控机制研究
    生防假单胞菌2P24中RNA结合蛋白RsmA/E对抗生素合成的差异调控
    • 批准号:
      31872020
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2018
    • 负责人:
      张力群
    • 依托单位: